Pharma companies set for strong performance in March 2025 quarter amid earning weakness

Sun Pharmaceutical, Dr Reddy's Laboratories, and Lupinare set to report healthy growth, driven by strong US portfolios and steady India performance. Ciplaand Torrent Pharmaceuticalsare likely to show resilience despite margin pressures, whi
Read more...